Morgan Stanley Finance LLC has issued $395,000 in principal amount of Callable Contingent Income Memory Securities due February 1, 2027, linked to the performance of Palantir Technologies Inc. Class A Common Stock. The securities, priced on July 27, 2026, offer a contingent coupon of 11.60% annually but expose investors to significant principal risk, including the possibility of losing their entire investment if the stock price declines sharply. The notes feature a callable structure that allows Morgan Stanley to redeem them early based on proprietary valuation models beginning October 30, 2026.

Key Points

  • NYSE: MS-PQ
  • Morgan Stanley Finance LLC issued $395,000 aggregate principal of Callable Contingent Income Memory Securities linked to Palantir Technologies Class A stock, maturing February 1, 2027
  • Securities offer an 11.60% annual contingent coupon payable only if the underlier closes at or above the coupon barrier level on observation dates; principal is fully at risk with potential 1% loss per 1% decline in stock level below the downside threshold
  • Callable beginning October 30, 2026 at three scheduled redemption dates; early redemption determination based on Morgan Stanley's risk-neutral valuation model

Security Structure and Principal-at-Risk Framework

The securities issued by Morgan Stanley Finance LLC are structured as principal-at-risk investments, meaning investors bear the full downside exposure to changes in the Palantir Technologies Class A stock price. Each security was issued at a stated principal amount of $1,000, with an aggregate issuance of $395,000. The securities are unsecured obligations of Morgan Stanley Finance LLC and are fully and unconditionally guaranteed by Morgan Stanley, but this guarantee does not protect against losses resulting from adverse movements in the underlier. The pricing date was July 27, 2026, with an original issue date of July 30, 2026, and a maturity date of February 1, 2027.

Unlike traditional debt instruments, these securities do not guarantee the return of principal at maturity if the final level of Palantir stock falls below a downside threshold level. The disclosure indicates that investors will lose 1% of principal for every 1% decline in the level of the underlier over the term of the securities if the final stock price is below the downside threshold. Under adverse market conditions, the payment at maturity could be significantly less than the stated principal amount and could theoretically reach zero. The prospectus explicitly states that investors in these securities must be willing to accept the risk of losing their entire initial investment.

Contingent Coupon Mechanics and Payment Conditions

The securities feature a contingent coupon structure that pays investors an annual coupon rate of 11.60%, but only under specified conditions tied to the performance of Palantir stock. The coupon will be paid on each coupon payment date only if the closing level of the underlier is greater than or equal to a coupon barrier level on the related observation date. This payment mechanism introduces uncertainty into what might otherwise appear as a relatively attractive yield for a short-duration security.

If the contingent coupon is not paid on any coupon payment date because the stock price falls below the coupon barrier level, the unpaid coupon amount becomes a "memory" coupon that carries forward to subsequent observation dates. The security documentation states that such unpaid contingent coupons will be paid on a later coupon payment date, but only if the closing level of the underlier subsequently reaches or exceeds the coupon barrier level on that date. Importantly, no additional interest accrues on previously unpaid contingent coupons from and after the end of their original interest periods. If the stock price never recovers to the coupon barrier level on any subsequent observation date, investors will receive no payment for those skipped coupons, and no interest is earned on the delayed payments.

Early Redemption Based on Risk-Neutral Valuation Models

The securities include a call feature that permits Morgan Stanley to redeem the notes early on any of three scheduled redemption dates: October 30, 2026, December 2, 2026, and December 31, 2026. However, the filing specifies that redemption will occur only if a risk-neutral valuation model indicates that early redemption is economically rational for Morgan Stanley compared to not redeeming on that date. The determination of whether to exercise this call is not automatic based on the performance of Palantir stock, but rather depends on inputs selected by the calculation agent on a business day no earlier than three business days before the observation date preceding each redemption date and no later than that observation date.

The valuation model takes into account prevailing reference market levels, volatilities, correlations, and Morgan Stanley's credit spreads as of the pricing date. If the securities are called, investors will receive the stated principal amount plus the contingent coupon with respect to the related interest period and any previously unpaid contingent coupons. The disclosure indicates that no further payments will be made on the securities once they have been redeemed. This call feature could result in early termination of the investment at a time that may not be advantageous for investors, particularly if Palantir stock is performing well and investors anticipated continuing to receive the elevated contingent coupon.

Pricing, Distribution, and Costs to Investors

The securities were priced at $1,000 per security, with a total aggregate principal amount of $395,000. The filing provides transparency regarding costs and distribution. The agent's commissions and fees were $2.50 per security, or $987.50 in total, with proceeds to Morgan Stanley Finance LLC of $997.50 per security, totaling $394,012.50. Morgan Stanley & Co., the distribution agent and an affiliate of the issuer, expects to sell all securities to an unaffiliated dealer at $997.50 per security for further sale to fee-based advisory accounts at the public price of $1,000 per security.

The estimated value on the pricing date was $984.60 per security, approximately $15.40 less than the issue price. This valuation takes into account the contingent nature of the coupon payments, the principal-at-risk structure, and the embedded call option held by Morgan Stanley. The securities will be sold only to investors purchasing them in fee-based advisory accounts, which may limit the potential distribution but ensures that purchasers are investing through accounts managed with fee-based advisory relationships. The pricing supplement notes that Morgan Stanley & Co. will not receive a sales commission with respect to the securities beyond the stated commissions and fees.

Credit Risk and Guarantor Obligations

Although the securities are fully and unconditionally guaranteed by Morgan Stanley, this guarantee does not eliminate all risks. The filing clearly discloses that all payments on the securities are subject to Morgan Stanley's credit risk. If Morgan Stanley defaults on its obligations, investors could lose some or all of their investment. The securities are unsecured obligations and investors will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets backing the notes. This means that in a default scenario, these securities rank alongside other unsecured creditors of Morgan Stanley.

Additionally, the securities are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank, except to the extent that Morgan Stanley itself is a bank holding company. Investors bear the full credit risk of Morgan Stanley Finance LLC and the guarantee provided by Morgan Stanley. The combination of principal-at-risk structure, contingent coupon mechanics, and Morgan Stanley credit risk creates a multi-layered set of risks that investors must evaluate.

Observation Dates and Payment Schedule

The securities have a final observation date of January 27, 2027, subject to postponement for non-trading days and certain market disruption events. The filing references observation dates and coupon payment dates that are set forth in a separate section titled "Observation Dates and Coupon Payment Dates," though the specific dates beyond those mentioned are not provided in detail in this pricing supplement. The final observation date determines the final level of Palantir stock, which is critical to calculating the payment at maturity. If the final level is greater than or equal to the downside threshold level, investors receive the stated principal amount plus any applicable contingent coupons at maturity.

The maturity date is February 1, 2027, giving these securities a very short duration of approximately six months from the original issue date. The compressed time horizon means that investors have limited opportunity to benefit from potential recoveries in Palantir stock if an adverse price movement occurs early in the holding period. The observation dates for determining coupon payments and the final observation date are subject to postponement for non-trading days and certain market disruption events, which could alter the timing of payments and the final stock price determination.

Investor Suitability and Risk Disclosure

The filing explicitly states that these securities are designed for investors who seek an opportunity to earn interest at a potentially above-market rate in exchange for accepting substantial risk. Specifically, the disclosure identifies the target investor profile as those willing to accept the risk of losing a significant portion or all of their principal, the risk of receiving no coupons over the entire term of the securities, and the risk of an early redemption of the securities based on the output of the risk-neutral valuation model used by Morgan Stanley. The 11.60% annual contingent coupon rate is presented as compensation for these risks.

A critical point emphasized in the prospectus is that investors will not participate in any appreciation of the underlier. The structure is asymmetrical: while investors bear the full downside risk of Palantir stock declines, they do not benefit from stock price appreciation above the coupon barrier level. If Palantir stock rises significantly, the contingent coupons will be paid, but the principal remains fixed at $1,000. This asymmetry reflects the embedded call option held by Morgan Stanley, which allows the company to terminate the investment and pocket the upside if the valuation model indicates redemption is economically rational.

Registration and Regulatory Framework

The securities are issued as part of Morgan Stanley Finance LLC's Series A Global Medium-Term Notes program and are registered under Securities and Exchange Commission Registration Statement Nos. 333-293641 and 333-293641-01. The pricing supplement itself was filed pursuant to SEC Rule 424(b)(2) on July 29, 2026, which is the standard procedure for offering documents of registered securities. The accompanying product supplement, tax supplement, and prospectus were dated April 8, 2026, and provide the foundational terms and conditions for this class of securities.

The regulatory filing emphasizes that the Securities and Exchange Commission and state securities regulators have not approved or disapproved the securities, or determined if the pricing supplement or accompanying documents are truthful or complete. The disclaimer notes that any representation to the contrary would constitute a criminal offense. This standard regulatory language underscores that the SEC's review process does not constitute an endorsement or validation of the investment merits of the securities, and investors must conduct their own independent analysis.

Hedging and Use of Proceeds

The filing references "Use of Proceeds and Hedging" in the accompanying product supplement, though specific details of Morgan Stanley's hedging strategy for these securities are not provided in the pricing supplement itself. Morgan Stanley Finance LLC receives net proceeds of $394,012.50 from the issuance after deducting agent commissions and fees. While the specific use of these proceeds is not detailed in the pricing supplement, the language suggests that investors should consult the product supplement for information regarding how Morgan Stanley intends to manage its hedge positions and allocate the proceeds from this issuance.

The hedging practices of Morgan Stanley are significant because they directly affect the issuer's ability to meet its obligations on the securities. If Morgan Stanley's hedging activities prove ineffective or if market conditions move adversely to the hedging strategy, this could potentially impact the issuer's financial condition. However, the primary vehicle for assessing these matters would be the product supplement and prospectus, which investors should review in conjunction with this pricing supplement.

Comparison to Ordinary Debt Securities and Market Context

The filing explicitly acknowledges that the securities involve risks not associated with an investment in ordinary debt securities. Ordinary corporate or government bonds typically provide fixed interest payments and a return of principal at maturity. In contrast, these Callable Contingent Income Memory Securities expose investors to stock market risk, coupon payment uncertainty, principal loss potential, and early redemption risk. The 11.60% annual contingent coupon rate, while appearing attractive, must be evaluated within the context of these substantial structural risks and the compressed six-month maturity.

These structured products are often marketed to sophisticated investors seeking enhanced yield in a low-interest-rate environment. The reference to fee-based advisory accounts in the distribution terms suggests that financial advisors are expected to play a significant role in explaining the risks and benefits to retail investors. The fact that the securities are sold exclusively through fee-based advisory accounts may provide some safeguard, as fee-based advisors typically have duties to ensure suitability and have incentives aligned differently than commission-based salespeople. Nevertheless, the inherent complexity and risk profile of these securities warrant careful evaluation by investors before committing capital.